Extract below from the June 2016 company newsletter:
"The Company is also planning to perform an interim analysis of the Phase II NASH Trial with a minimum 30 patients. 25 patients have currently completed treatment in the trial. The results of this analysis will be available before the end of the year"
If the results are positive then this will significantly boost the share price imo. The fact that the company is doing this is a good sign that they are confident in the results.
Extract below from the June 2016 company newsletter: "The...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
